相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。State-dependent block of HERG potassium channels by R-roscovitine: implications for cancer therapy
Sindura B. Ganapathi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
The Timothy syndrome mutation of cardiac CaV1.2 (L-type) channels: multiple altered gating mechanisms and pharmacological restoration of inactivation
Viktor Yarotskyy et al.
JOURNAL OF PHYSIOLOGY-LONDON (2009)
The separation of antagonist from agonist effects of trisubstituted purines on CaV2.2 (N-type) channels
Zafir Buraei et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Roscovitine, a cyclin-dependent kinase inhibitor, affects several gating mechanisms to inhibit cardiac L-type (Ca(V) 1.2) calcium channels
V. Yarotskyy et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Roscovitine-activated HIP2 kinase induces phosphorylation of wt p53 at Ser-46 in human MCF-7 breast cancer cells
Jozefa Wesierska-Gadek et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days
C. Benson et al.
BRITISH JOURNAL OF CANCER (2007)
Roscovitine differentially affects CaV2 and Kv channels by binding to the open state
Zafir Buraei et al.
NEUROPHARMACOLOGY (2007)
Effects of L-type Ca2+ channel antagonism on ventricular arrhythmogenesis in murine hearts containing a modification in the Scn5a gene modelling human long QT syndrome 3
Glyn Thomas et al.
JOURNAL OF PHYSIOLOGY-LONDON (2007)
Calcium and arrhythmogenesis
Henk E. D. J. Ter Keurs et al.
PHYSIOLOGICAL REVIEWS (2007)
Ca2+ enhances U-type inactivation of N-type (CaV2.2) calcium current in rat sympathetic neurons
Yong Sook Goo et al.
JOURNAL OF NEUROPHYSIOLOGY (2006)
The effects of presynaptic calcium channel modulation by roscovitine on transmitter release at the adult frog neuromuscular junction
Soyoun Cho et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Molecular physiology of cardiac repolarization
JM Nerbonne et al.
PHYSIOLOGICAL REVIEWS (2005)
Slowed N-type calcium channel (CaV2.2) deactivation by the cyclin-dependent kinase inhibitor roscovitine
Z Buraei et al.
BIOPHYSICAL JOURNAL (2005)
In vitro and in vivo pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine and CYC202
FI Raynaud et al.
CLINICAL CANCER RESEARCH (2005)
Assessment of the efficacy, optimal dosage, and safety of diltiazem in early treatment of unstable angina pectoris
R Bai
CLINICAL CARDIOLOGY (2005)
Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations
I Splawski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Calcium channel blockers in the treatment of disease
KS Elmslie
JOURNAL OF NEUROSCIENCE RESEARCH (2004)
Functional roles of cytoplasmic loops and pore lining transmembrane helices in the voltage-dependent inactivation of HVA calcium channels
SC Stotz et al.
JOURNAL OF PHYSIOLOGY-LONDON (2004)
L-type Ca2+ channels in Ca2+ channelopathies
J Striessnig et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Cav1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism
I Splawski et al.
CELL (2004)
A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease - The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial
CJ Pepine et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Roscovitine and other purines as kinase inhihitors. From starfish oocytes to clinical trials
L Meijer et al.
ACCOUNTS OF CHEMICAL RESEARCH (2003)
Effects of nicardipine on coronary, vertebral and renal arterial flows in patients with essential hypertension
S Suzuki et al.
HYPERTENSION RESEARCH (2003)
Efficacy and safety of a once daily graded-release diltiazem formulation in essential hypertension
SP Glasser et al.
AMERICAN JOURNAL OF HYPERTENSION (2003)
In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine)
SJ McClue et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Roscovitine inhibits ongoing DNA synthesis in human cervical cancer
L Vitali et al.
CANCER LETTERS (2002)
Critical determinants of Ca2+-dependent inactivation within an EF-hand motif of L-type Ca2+ channels
BZ Peterson et al.
BIOPHYSICAL JOURNAL (2000)
分享论文
